Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
J Neurol ; 270(12): 6113-6123, 2023 Dec.
Article in English | MEDLINE | ID: mdl-37668701

ABSTRACT

BACKGROUND: Acute ischemic stroke (AIS) is an immediate emergency whose management is becoming more and more personalized while facing a limited number of neurologists with high expertise. Clinical decision support systems (CDSS) are digital tools leveraging information and artificial intelligence technologies. Here, we present the Strokecopilot project, a CDSS for the management of the acute phase of AIS. It has been designed to support the evidence-based medicine reasoning of neurologists regarding the indications of intravenous thrombolysis (IVT) and endovascular treatments (ET). METHODS: Reference populations were manually extracted from the field's main guidelines and randomized clinical trials (RCT). Their characteristics were harmonized in a computerized reference database. We developed a web application whose algorithm identifies the reference populations matching the patient's characteristics. It returns the latter's outcomes in a graphical user interface (GUI), whose design has been driven by real-world practices. RESULTS: Strokecopilot has been released at www.digitalneurology.net . The reference database includes 25 reference populations from 2 guidelines and 15 RCTs. After a request, the reference populations matching the patient characteristics are displayed with a summary and a meta-analysis of their results. The status regarding IVT and ET indications are presented as "in guidelines", "in literature", or "outside literature references". The GUI is updated to provide several levels of explanation. Strokecopilot may be updated as the literature evolves by loading a new version of the reference populations' database. CONCLUSION: Strokecopilot is a literature-based CDSS, developed to support neurologists in the management of the acute phase of AIS.


Subject(s)
Brain Ischemia , Decision Support Systems, Clinical , Ischemic Stroke , Stroke , Humans , Stroke/drug therapy , Brain Ischemia/drug therapy , Fibrinolytic Agents/therapeutic use , Thrombolytic Therapy/methods , Ischemic Stroke/drug therapy , Treatment Outcome
2.
Cerebrovasc Dis Extra ; 10(3): 174-180, 2020 Dec 07.
Article in English | MEDLINE | ID: mdl-33285543

ABSTRACT

INTRODUCTION: Severe SARS-CoV-2 infection induces COVID-19 along with venous thromboembolic occurrences particularly in intensive care units. For non-severe COVID-19 patients affected by neurovascular diseases, the prevalence of deep venous thrombosis (DVT) is unknown. The aim of our study was to report data obtained after systematic Doppler ultrasound scanning (DUS) of lower limbs in such patients. METHODS: Between March 20 and May 2, 2020, the deep venous system of 13 consecutive patients diagnosed with neurovascular diseases and non-severe COVID-19 was investigated with a systematic bedside DUS. RESULTS: Thirteen patients were enrolled in the study including 9 acute ischaemic strokes, 1 occlusion of the ophthalmic artery, 1 transient ischaemic attack, 1 cerebral venous thrombosis and 1 haemorrhagic stroke. On admission, the median National Institute of Health Stroke Scale (NIHSS) score was of 6 (IQR, 0-20). During the first week after admission, and despite thromboprophylaxis, we found a prevalence of 38.5% of asymptomatic calves' DVT (n = 5). One patient developed a symptomatic pulmonary embolism and 2 other patients died during hospitalization. The outcome was positive for the other patients with a discharge median NIHSS score of 1 (IQR, 0-11). DISCUSSION/CONCLUSION: Despite thromboprophylaxis, systematic bedside DUS showed a high prevalence (38.5%) of asymptomatic DVT in non-severe COVID-19 patients suffering from a neurovascular disease. In the absence of a reliable marker of DVT, we suggest that this non-invasive investigation could be an interesting tool to monitor peripheral venous thrombotic complications in such patients.

3.
Hawaii J Med Public Health ; 72(5 Suppl 1): 77-86, 2013 May.
Article in English | MEDLINE | ID: mdl-23901366

ABSTRACT

Non-communicable diseases (NCD) have been declared a health emergency in the US-affiliated Pacific Islands (USAPI). This assessment, funded by the National Institutes of Health, was conducted on Ebeye Island of Kwajelein Atoll, Republic of the Marshall Islands (RMI) to describe the burdens due to selected NCD (diabetes, heart disease, hypertension, stroke, chronic kidney disease); assess the system of service capacity and activities for service delivery, data collection, and reporting; and identify the key issues that need to be addressed. Findings reveal that the risk factors of poor diet, lack of physical activity, and lifestyle behaviors lead to overweight and obesity and subsequent NCD that impact the morbidity and mortality of the population. Population survey of the RMI show that 62.5% of the total population is overweight or obese with a dramatic increase from the 15-24 year old (10.6%) and the 25-64 year old (41.9%) age groups. The leading causes of death were septicemia, renal failure, pneumonia, cancer, and myocardial infarction. Other findings show gaps in the system of administrative, clinical, and support services to address these NCD. All health care in Ebeye is provided in one setting and there is collaboration, coordination, and communication among medical and health care providers. The Book of Protocols for the Kwajalein Atoll Health Care Bureau provides the guidelines, standards, and policy and procedures for the screening, diagnosis, and management of diabetes and other NCDs. Based on these findings, priority issues and problems to be addressed for the administrative, clinical, and data systems were identified.


Subject(s)
Diabetes Mellitus, Type 2/epidemiology , Diabetes Mellitus, Type 2/prevention & control , Health Services Administration , Health Services Needs and Demand , Obesity/epidemiology , Adolescent , Adult , Aged , Aged, 80 and over , Cardiovascular Diseases/mortality , Cardiovascular Diseases/prevention & control , Child , Child, Preschool , Diabetes Complications/prevention & control , Diabetes Mellitus, Type 2/therapy , Female , Health Services Administration/economics , Health Services Administration/legislation & jurisprudence , Health Surveys , Health Workforce , Humans , Information Systems , Insurance, Health , Male , Micronesia/epidemiology , Middle Aged , Needs Assessment , Neoplasms/mortality , Obesity/complications , Obesity/prevention & control , Practice Guidelines as Topic , Prevalence , Registries , Renal Insufficiency, Chronic/mortality , Renal Insufficiency, Chronic/therapy , Risk Factors , Tuberculosis, Pulmonary/epidemiology , Young Adult
4.
Clin Infect Dis ; 38(1): 1-9, 2004 Jan 01.
Article in English | MEDLINE | ID: mdl-14679441

ABSTRACT

In December 2000, physicians in the Republic of the Marshall Islands reported the first known outbreak of Vibrio cholerae O1 infection (biotype El Tor, serotype Ogawa) from this country. In a matched case-control study on Ebeye Island, patients with cholera (n=53) had greater odds than persons without cholera (n=104) to have drunk adequately chlorinated water collected from a US military installation on neighboring Kwajalein Island and transported back to Ebeye (matched odds ratio [MOR], 8.0; P=.01). Transporting or storing drinking water in a water cooler with a spout and a tight-fitting lid was associated with reduced odds of illness (MOR, 0.24; P<.01), as was drinking bottled water (MOR, 0.08; P<.01), boiled water (MOR, 0.47; P=.02), or water flavored with powdered drink mixes (MOR, 0.18; P<.01). No cases of cholera were reported among Kwajalein residents. This outbreak highlights the critical importance of handling and storing drinking water safely, especially during outbreaks of gastrointestinal illness.


Subject(s)
Cholera/epidemiology , Disease Outbreaks , Vibrio cholerae , Water Supply , Adolescent , Adult , Aged , Child , Child, Preschool , Chlorine/pharmacology , Female , Humans , Hydrotherapy , Male , Micronesia/epidemiology , Middle Aged , Vibrio cholerae/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...